Specialist Medical Intervention & Lightning Evaluation: Comparing specialist medical care with specialist medical care plus the Lightning Process for Chronic Fatigue Syndrome or Myalgic Encephalopathy (CFS/ME)

ISRCTN ISRCTN81456207
DOI https://doi.org/10.1186/ISRCTN81456207
Secondary identifying numbers Version 9 June 2012
Submission date
07/06/2012
Registration date
31/07/2012
Last edited
12/03/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) is relatively common in teenagers and can be serious. Over half of teenagers with CFS/ME are bed bound at some stage and on average, they miss one year of school. Little is known about how to treat CFS/ME and even though over 250 teenagers a year use the Lightning Process as an intervention for CFS/ME, no studies have investigated whether it is either effective or safe.
Specialist Medical Care is the current treatment teenagers normally receive if they have CFS/ME. They are offered either activity management, Cognitive Behavioural Therapy (CBT), graded exercise or a mixture of all three depending on their goals and needs. The timing and number of the sessions varies but on average, most teenagers have a follow-up phone call 2 weeks after assessment followed by three or four follow-up sessions, spread out over 3 to 6 months usually at 6-weekly intervals. Sessions are normally run as family-based sessions with a member of the Bath Specialist CFS/ME team (physiotherapist, psychologist or occupational therapist).
The Lightning Process is based on the idea that the body and mind work together to affect your health. It is a training programme, run as a course on three consecutive days (for 3 hours 45 minutes a day) in a group with up to five other young people aged between 12 and 18 years old. The course is run by a Lightning Process Practitioner. Lightning Process Practitioners are trained in Neuro Linguistic Programming (NLP), life coaching, clinical hypnotherapy and the Lightning Process – they are not medically trained. The course is run as a mixture of group and individual discussions with theory and practical sessions each day. In the theory session, teenagers learn about stress and its physical effects, how the mind and body interact and how thought processes can be helpful and unhelpful. In the practical session, teenagers identify goals they wish to achieve (for example, standing for longer) and are given different ways to think about and prepare for this. They then have the chance to practise this on the course with the Lightning Process practitioner there to support them. A parent can attend and a researcher may be present to watch the session. Teenagers are given up to 30 minutes homework each day so they can continue to practise the skills they have learnt using a goal they identified on the course.
This aim of this study is to investigate whether adding the Lightning Process to specialist medical care is effective or cost effective. We have already shown that it is feasible to recruit children into this study.

Who can participate?
Children with CFS/ME aged 12 – 18 years old.

What does the study involve?
Children will be randomly allocated to receive either specialist medical care or specialist medical care plus the Lightning Process.
Specialist Medical Treatment: children and their families are offered a variety of treatments centred around graded activity and involves a follow-up phone call at 2 weeks followed by family-based rehabilitation consultations at approximately 6 weeks (1 hour), 3 months (1 hour), and 4.5 months (1 hour). Children who have high levels of anxiety are offered three individual sessions of CBT every 2 weeks over a 6-week period. Other interventions such as Graded Exercise Therapy (GET) are available for children and young people if needed.
Specialist Medical Treatment plus the Lightning Process: In addition to the specialist medical care detailed above, young people and their parents will be asked to read the information about the Lightning Process on the website or using information sheets. If the young person is well enough, they will be asked to read a book about the Lightning Process. If they are unable to read the book, they will be asked to listen to an audio book. Children/young people and their parents will be asked to complete an assessment form (which will take about 10 minutes) where they are asked to identify their goals and describe what they learnt from reading the book. After this they will have a telephone call with a Lightning Process practitioner (LPP) (usually about 20 minutes). This is used to check that the young person and their parents are happy about attending the course, checks the goals identified by the young person and is an opportunity for the young person and their parents to ask further questions. If the young person and their family are happy to continue, the young person will be given a date to attend a course.
The course is three sessions on three consecutive days. Each session is 3 hours 45 minutes long. Group sessions include four to five young people between 12 – 18 years of age who live within the region covered by the CFS/ME service. During the group, children and young people will have a theory session and a practical session.
The LPP will then arrange two follow-up phone calls with the young person and parents within 2 weeks of the course and then about 6-8 weeks later.

What are the possible benefits and risks of participating?
There are no specific benefits for children participating in this study. We do not think there are any side effects of the interventions but because the Lightning Process has not been tested before, we will be monitoring all interventions and closely following up all young people who take part. Those taking part will need to complete questionnaires 3 months after the intervention as well as the normal time points (6 months and annually). They will also need to complete two more questionnaires at each time point which we think will take about 5 minutes to complete. Some parents of children who receive Specialist Medical Care and the Lightning Process have told us that they find the two approaches, and the language used in them, are different. If this is a problem for children and young people, we will offer support.

Where is the study run from?
The study is run by Dr Esther Crawley who leads the Bath paediatric specialist CFS/ME clinical service at the Royal National Hospital for Rheumatic Diseases. The research is being done by Dr Crawley’s research team at the University of Bristol. The Bath paediatric specialist CFS/ME clinical service runs clinics throughout Somerset, Bath and North East Somerset, Wiltshire and Gloucester and children are recruited from all clinics.

When is the study starting and how long is it expected to run for?
The study started as a feasibility study (to see if a study was possible) in October 2010. We have now shown that it is possible to run the study and are planning to convert the study to a randomised trial. We anticipate that this will start in September and will run for a further 8 months.

Who is funding the study?
The study is funded by the Linbury Trust and the Ashden Trust

Who is the main contact?
Dr Esther Crawley
esther.crawley@bristol.ac.uk

Study website

Contact information

Dr Esther Crawley
Scientific

Center of Child and Adolescent Health
School of Social and Community Medicine
Oakfield House
Oakfield Grove
Bristol
BS8 2BN
United Kingdom

Phone +44 (0)1225 331 4099
Email esther.crawley@bristol.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Patient information material can be found at http://www.bristol.ac.uk/ccah/research/childdevelopmentdisability/chronic-fatigue/smile.html
Scientific titleComparing specialist medical care with specialist medical care plus the Lightning Process for Chronic Fatigue Syndrome or Myalgic Encephalopathy (CFS/ME) - a randomised controlled trial
Study acronymSMILE
Study hypothesisAdding the Lightning Process to specialist medical treatment will not change the effectiveness or cost effectiveness of treatment.
Ethics approval(s)South West 2 Local Research Ethics Committee, 8th September 2010, ref: 10/H0206/32. Amendement approved on 31/05/2011
ConditionChronic Fatigue Syndrome / Myalgic Encephalopathy (CFS/ME)
InterventionSpecialist Medical Treatment: children and their families are offered a variety of treatment options that are recommended in NICE guidelines. Typically this is centred around graded activity and involves a follow up phone call at 2 weeks followed by family based rehabilitation consultations at approximately 6 weeks (1 hour), 3 months (1 hour), and 4.5 months (1 hour). The number and timing of the sessions are agreed with the child and family and varies depending on the needs and goals of the child. Children who have high levels of anxiety are offered 3 individual sessions of Cognitive behavioral therapy (CBT) every 2 weeks over a 6 week period. Other interventions such as Graded Exercise Therapy (GET) are available for children and young people if needed.

Specialist Medical Treatment plus the Lightning Process: In addition to the specialist Medical Care detailed above, young people and their parents will be asked to read the information about the Lightning Process on the website or using information sheets. If the young person is well enough, they will be asked to read a book about the Lightning Process. If they are unable to read the book, they will be asked to listen to an audio book. Children/young people and their parents will be asked to complete an assessment form (which will take about 10 minutes) where they are asked to identify their goals and describe what they learnt from reading the book. After this they will have a telephone call with a Lightning Process practitioner (LPP) (usually approximately 20 minutes). This is used to check that the young person and their parents are happy about attending the course, checks the goals identified by the young person and is an opportunity for the young person and their parents to ask further questions. If the young person and their family are happy to continue, the young person will be given a date to attend a course.

The course is 3 sessions on 3 consecutive days. Each session is 3 hours 45 minutes long. Group sessions include 4 to 5 young people between 12 – 18 years of age who live within the region covered by the CFS/ME service. During the group, children and young people will have a theory session and a practical session.

The theory session will include taught elements on the stress response, how the mind-body interacts and how thought processes can be helpful and negative. The language used by young people will be discussed and in some cases challenged. Young people will be encouraged to think about what they may be able to take responsibility for and change. The taught sessions are followed by a group discussion.

The practical session is used to put some of the skills learnt into practise. Young people identify a goal they wish to achieve (such as standing for longer) and are then given alternative ways to think about and prepare for this. This involves using different cognitive (thinking) strategies before and during the goal is attempted. Young people are also asked to identify a goal in which they can practise the strategies in the afternoon or evening. This goal will usually be short but could be an activity that is up to 30 minutes long.

The LPP will then arrange two follow up phone calls with the young person and parents within 2 weeks of the course and then approximately 6 to 8 weeks later.
Intervention typeOther
Primary outcome measureCurrent primary outcome measures as of 12/03/2018:
1. SF 36 physical function short form at 6 months

Previous primary outcome measures:
1. Chalder Fatigue Scale at 6 months
2. SF 36 physical function short form at 6 months
Secondary outcome measuresCurrent secondary outcome measures as of 12/03/2018:
1. Chalder Fatigue scale and SF-36 physical function short term at 6 months and 12 months
2. School attendance (6 months and 12 months)
3. Health resource use
4. Parental loss of earnings
5. Anxiety and depression (6 months and 12 months)

Previous secondary outcome measures:
1. Chalder Fatigue scale and SF-36 physical function short term (12 months)
2. School attendance (6 months and 12 months)
3. Health resource use
4. Parental loss of earnings
5. Anxiety and depression (6 months and 12 months)
Overall study start date01/08/2012
Overall study end date31/03/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants120
Participant inclusion criteriaChildren will be included if they have CFS/ME and are between 12 and 18 years old
Participant exclusion criteria1. They are too severely affected to attend hospital appointments (defined as children and young people that do not regularly leave their house)
2. If they or their parents have insufficient English to either understand the Patient Information Sheet (PIS) and consent form to take part in the Lightning Process or take part in the interviews
Recruitment start date01/08/2012
Recruitment end date31/03/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Center of Child and Adolescent Health
Bristol
BS8 2BN
United Kingdom

Sponsor information

Royal National Hospital for Rheumatic Diseases (UK)
Hospital/treatment centre

c/o Dr Jane Carter
Upper Borough Walls
Bath
BA1 1RL
England
United Kingdom

Email info@rnhrd.nhs.uk
ROR logo "ROR" https://ror.org/05va5gy74

Funders

Funder type

Charity

The Linbury Trust (UK)

No information available

The Ashden Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryStored in repository
Publication and dissemination plan
IPD sharing planGiven the nature of this dataset, access is controlled. Requests are referred to the University of Bristol Data Access Committee for approval before data can be released under an appropriate data access agreement. For details on how to access data, see the repository record at http://dx.doi.org/10.5523/bris.1myzti8qnv48g2sxtx6h5nice7.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 05/12/2013 Yes No
Protocol article protocol 26/12/2013 Yes No
Results article results 01/12/2015 Yes No
Results article results 01/02/2018 Yes No
HRA research summary 28/06/2023 No No

Editorial Notes

12/03/2018: The primary and secondary outcome measures were updated.
23/02/2018: The participant level data sharing statement has been added.
21/02/2018: The trial website has been updated to the current website address.
26/02/2016: Publication reference added.

Springer Nature